Emotion regulation in substance use disorders: a systematic review and meta-analysis.
Alcohol use disorder
cocaine addiction
emotion regulation
methamphetamine
opioid use disorder
substance use disorders
Journal
Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
21
11
2021
accepted:
19
06
2022
pubmed:
20
7
2022
medline:
6
12
2022
entrez:
19
7
2022
Statut:
ppublish
Résumé
The ability to regulate emotions effectively has been associated with resilience to psychopathology. Individuals with substance use disorders (SUDs) have been shown to have higher levels of negative emotionality, with some evidence suggesting impairment in emotion regulation compared with individuals without SUDs. However, no previous attempt has been made to systematically review the literature to assess the magnitude of this difference. We aimed to assess the association between SUD diagnosis and emotion regulation as measured by the Difficulties in Emotion Regulation Scale (DERS) and Emotion Regulation Questionnaire (ERQ) through a systematic review and meta-analysis of existing findings. The systematic review was conducted using PubMed, PsycINFO and Embase. We examined cross-sectional studies that compared a SUD group with a control group and measured emotion regulation using the DERS or the ERQ. The primary analysis focused on papers using the DERS, as this was the predominant instrument in the literature. Twenty-two studies met our primary analysis criteria, representing 1936 individuals with a SUD and 1567 controls. Individuals with SUDs relative to controls had significantly greater DERS scores, with a mean difference of 21.44 [95% confidence interval (CI) = 16.49-26.40, P < 0.001] and Hedges' g = 1.05 (95% CI = 0.86-1.24, P < 0.001). The difference was robust, remaining significant after removing outliers and studies with high risk of bias. Individuals with SUDs demonstrated poorer emotion regulation on each subscale of the DERS, with the largest deficits in the Strategies and Impulse subscales. The ERQ analysis revealed greater use of expressive suppression in those with SUDs relative to controls (Hedges' g = 0.76, 95% CI = 0.25-1.28, P = 0.004). People with substance use disorders appear to have greater difficulties in emotion regulation than people without substance use disorders.
Sections du résumé
BACKGROUND AND AIMS
The ability to regulate emotions effectively has been associated with resilience to psychopathology. Individuals with substance use disorders (SUDs) have been shown to have higher levels of negative emotionality, with some evidence suggesting impairment in emotion regulation compared with individuals without SUDs. However, no previous attempt has been made to systematically review the literature to assess the magnitude of this difference. We aimed to assess the association between SUD diagnosis and emotion regulation as measured by the Difficulties in Emotion Regulation Scale (DERS) and Emotion Regulation Questionnaire (ERQ) through a systematic review and meta-analysis of existing findings.
METHODS
The systematic review was conducted using PubMed, PsycINFO and Embase. We examined cross-sectional studies that compared a SUD group with a control group and measured emotion regulation using the DERS or the ERQ. The primary analysis focused on papers using the DERS, as this was the predominant instrument in the literature.
RESULTS
Twenty-two studies met our primary analysis criteria, representing 1936 individuals with a SUD and 1567 controls. Individuals with SUDs relative to controls had significantly greater DERS scores, with a mean difference of 21.44 [95% confidence interval (CI) = 16.49-26.40, P < 0.001] and Hedges' g = 1.05 (95% CI = 0.86-1.24, P < 0.001). The difference was robust, remaining significant after removing outliers and studies with high risk of bias. Individuals with SUDs demonstrated poorer emotion regulation on each subscale of the DERS, with the largest deficits in the Strategies and Impulse subscales. The ERQ analysis revealed greater use of expressive suppression in those with SUDs relative to controls (Hedges' g = 0.76, 95% CI = 0.25-1.28, P = 0.004).
CONCLUSIONS
People with substance use disorders appear to have greater difficulties in emotion regulation than people without substance use disorders.
Identifiants
pubmed: 35851975
doi: 10.1111/add.16001
pmc: PMC10087816
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-47Informations de copyright
© 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Références
Am J Drug Alcohol Abuse. 2013 Nov;39(6):414-23
pubmed: 24200211
Front Psychiatry. 2020 Feb 03;10:1028
pubmed: 32116829
Psychiatr Q. 2017 Dec;88(4):807-825
pubmed: 28194549
Br J Clin Psychol. 2018 Jun;57(2):186-202
pubmed: 29277906
J Consult Clin Psychol. 2011 Jun;79(3):307-18
pubmed: 21534653
Encephale. 2019 Jun;45(3):226-231
pubmed: 30528180
Front Psychiatry. 2018 Jul 31;9:328
pubmed: 30108525
Advers Resil Sci. 2020 Jun;1(2):107-119
pubmed: 33768210
Addiction. 2023 Jan;118(1):30-47
pubmed: 35851975
Psychiatry Res. 2017 Jun;252:223-230
pubmed: 28285249
Eat Disord. 2020 Mar-Apr;28(2):142-156
pubmed: 32301683
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Psychiatry Res. 2021 Feb;296:113662
pubmed: 33406445
Addict Behav. 2015 Aug;47:70-3
pubmed: 25885662
Nat Hum Behav. 2021 Oct;5(10):1443-1457
pubmed: 34545236
Drug Alcohol Depend. 2016 Apr 1;161:163-70
pubmed: 26880595
J Cogn Neurosci. 2002 Nov 15;14(8):1215-29
pubmed: 12495527
Br J Clin Psychol. 2012 Sep;51(3):239-60
pubmed: 22803933
Lancet. 2019 Aug 31;394(10200):781-792
pubmed: 31478502
J Psychiatr Res. 2014 Nov;58:175-80
pubmed: 25171941
Obes Surg. 2014 Nov;24(11):1975-80
pubmed: 24908245
Subst Use Misuse. 2018 Sep 19;53(11):1915-1918
pubmed: 29465278
Addiction. 2020 Nov;115(11):2130-2139
pubmed: 32350970
Eur Addict Res. 2016;22(6):292-300
pubmed: 27438781
Emotion. 2020 Feb;20(1):1-9
pubmed: 31961170
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Clin Med. 2021 Mar 23;10(6):
pubmed: 33806849
Subst Use Misuse. 2020;55(2):252-260
pubmed: 31519134
Addict Behav. 2015 Mar;42:57-62
pubmed: 25462655
J Adolesc Health. 2020 Mar;66(3):308-314
pubmed: 31727551
Borderline Personal Disord Emot Dysregul. 2019 Mar 05;6:6
pubmed: 30873282
J Interpers Violence. 2013 Jul;28(11):2290-314
pubmed: 23422845
Subst Use Misuse. 2017 Jul 3;52(8):1085-1097
pubmed: 28323517
Addict Behav. 2021 Apr;115:106785
pubmed: 33360277
Subst Use Misuse. 2018 Dec 6;53(14):2320-2329
pubmed: 29889648
Clin Respir J. 2018 Nov;12(11):2606-2612
pubmed: 30256526
Drug Alcohol Depend. 2013 Dec 1;133(2):338-43
pubmed: 23906994
Drug Alcohol Depend. 2007 Jul 10;89(2-3):298-301
pubmed: 17276626
Addict Behav. 2018 Sep;84:86-91
pubmed: 29631095
Addict Behav Rep. 2021 May 27;14:100354
pubmed: 34141856
Psychiatr Hung. 2021;36(1):53-66
pubmed: 33686015
Addict Behav. 2018 May;80:6-13
pubmed: 29306117
Addict Behav. 2019 Nov;98:106035
pubmed: 31302312
Addict Behav. 2006 May;31(5):811-20
pubmed: 15993006
Psychol Assess. 2015 Sep;27(3):944-54
pubmed: 25774638
Behav Brain Res. 2017 Jun 1;327:121-132
pubmed: 28057531
Am J Drug Alcohol Abuse. 2019;45(1):97-107
pubmed: 30216741
Alcohol Clin Exp Res. 2018 Jul 5;:
pubmed: 29975424
Encephale. 2012 Oct;38(5):390-6
pubmed: 23062452
Drug Alcohol Depend. 2021 Nov 1;228:109076
pubmed: 34600250
Am J Drug Alcohol Abuse. 2011 Jan;37(1):37-42
pubmed: 21091162
Alcohol Clin Exp Res. 2015 Dec;39(12):2471-9
pubmed: 26613633
Drug Alcohol Depend. 2020 Jun 11;213:108104
pubmed: 32570138
J Subst Abuse Treat. 2018 Aug;91:49-56
pubmed: 29910014
Drug Alcohol Depend. 2020 Mar 1;208:107842
pubmed: 31935570
J Pers Soc Psychol. 2003 Aug;85(2):348-62
pubmed: 12916575
Front Psychiatry. 2014 Sep 26;5:130
pubmed: 25309462
J Aggress Maltreat Trauma. 2016;25(3):305-314
pubmed: 27313442
Subst Use Misuse. 2021;56(7):950-961
pubmed: 33754955
Addict Behav. 2008 Feb;33(2):388-94
pubmed: 18023295
Addict Behav. 2017 Aug;71:75-81
pubmed: 28273489
Int J Neuropsychopharmacol. 2020 Jul 29;23(7):409-416
pubmed: 32221527
Alcohol Clin Exp Res. 2014 May;38(5):1409-15
pubmed: 24512139
Psychol Rep. 2014 Feb;114(1):14-9
pubmed: 24765706
Brain Imaging Behav. 2021 Aug;15(4):2187-2198
pubmed: 33222012
J Clin Psychol. 2012 Sep;68(9):989-1007
pubmed: 22653763
Drug Alcohol Depend. 2016 Jun 01;163 Suppl 1:S13-8
pubmed: 27306725
Front Integr Neurosci. 2012 Nov 07;6:101
pubmed: 23162443
Alcohol Clin Exp Res. 2016 Sep;40(9):1884-94
pubmed: 27501356
Am J Addict. 2011 Mar-Apr;20(2):151-60
pubmed: 21314758
Neuropsychopharmacology. 2008 Jul;33(8):1798-806
pubmed: 17895916
Appetite. 2018 Jan 1;120:367-373
pubmed: 28958901
Front Hum Neurosci. 2020 Nov 27;14:571035
pubmed: 33328928
Psychiatry Res Neuroimaging. 2016 Feb 28;248:30-8
pubmed: 26792587